Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

BUY
$1.22 - $1.95 $4,880 - $7,800
4,000 New
4,000 $6,000
Q1 2022

Apr 29, 2022

SELL
$1.15 - $1.97 $4,600 - $7,880
-4,000 Closed
0 $0
Q3 2021

Oct 21, 2021

BUY
$1.94 - $2.55 $7,760 - $10,200
4,000 New
4,000 $8,000
Q2 2021

Jul 26, 2021

SELL
$1.69 - $2.67 $6,760 - $10,680
-4,000 Closed
0 $0
Q1 2021

May 05, 2021

BUY
$1.79 - $2.91 $7,160 - $11,640
4,000 New
4,000 $8,000
Q1 2020

Apr 24, 2020

SELL
$0.96 - $1.57 $3,840 - $6,280
-4,000 Closed
0 $0
Q4 2019

Feb 27, 2020

BUY
$1.1 - $1.32 $4,400 - $5,280
4,000 New
4,000 $5,000

Others Institutions Holding VBLT

About Vascular Biogenics Ltd.


  • Ticker VBLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,348,896
  • Description
  • Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...
More about VBLT
Track This Portfolio

Track Total Clarity Wealth Management, Inc. Portfolio

Follow Total Clarity Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.